PENG Block Plus Lateral Femoral Cutaneous Nerve Block for Posterolateral-approached Total Hip Arthroplasty

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-01

Study Completion Date

2023-05-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to analyze the effect of Pericapsular Nerve Group (PENG) Block combined with lateral femoral cutaneous nerve block vs. PENG block combined with wound infiltration for analgesia after elective hip replacement performed with a posters-lateral approach.

Half of participants will receive a PENG Block combined with femoral lateral cutaneous nerve block, while the other half will receive PENG Block combined with wound infiltration

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

PENG Block Combined to Wound Infiltration for Hip Replacement

NCT04306133

Postoperative Pain Analgesia Hip Arthropathy +3 more

COMPLETED NA

Pericapsular Nerve Group (PENG) Block Combined With Lateral Femoral Cutaneous Nerve (LFCN) Block or Wound Infiltration for Postoperative Analgesia in Anterior Approach Total Hip Arthroplasty: A Randomized Controlled Trial

NCT07284615

Arthropathy of Hip Hip Arthropathy Locoregional Anesthesia +4 more

NOT_YET_RECRUITING NA

PENG and LFCN Block Versus Lumbar Plexus Block for Postoperative Analgesia After Total Hip Arthroplasty

NCT05652075

Post Operative Pain Regional Block

UNKNOWN NA

PENG Block and Lateral Femoral Cutaneous Nerve Block For Hip Replacement Surgery

NCT06040879

POSTOPERATIVE ANALGESIA

COMPLETED NA

PENG Block Plus Local Infiltration Compared to PENG Block Alone in Hip Surgery

NCT05773365

Pain Hip Fractures Postoperative Pain +1 more

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Postoperative Pain Acute Pain Analgesia Hip Arthropathy Postoperative Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PENG block plus Femoral Cutaneous Nerve Block

Participants receiving PENG block combined to Lateral Femoral Cutaneous Nerve Block

Group Type EXPERIMENTAL

PENG Block

Intervention Type PROCEDURE

At the end of surgery, in Post Anesthesia Recovery Room (PACU), PENG block with 20 mL of 0.5 % Ropivacaine will be executed as described by Giron-Arango et al. using a low frequency curvilinear probe. A 22G 80 mm needle (Stimuplex Ultra 360, B.Braun) will be used.

Lateral Femoral Cutaneous Nerve Block

Intervention Type PROCEDURE

At the end of surgery, in Post Anesthesia Recovery Room (PACU), ultrasound guided Lateral Femoral Cutaneous Nerve Block will be performed with 10 mL of 0.5 % Ropivacaine using a high frequency linear probe. A 22G 50 mm needle (Stimuplex Ultra 360, B.Braun) will be used.

PENG block plus Wound Infiltration

Participants receiving PENG block combined to wound infiltration

Group Type ACTIVE_COMPARATOR

PENG Block

Intervention Type PROCEDURE

At the end of surgery, in Post Anesthesia Recovery Room (PACU), PENG block with 20 mL of 0.5 % Ropivacaine will be executed as described by Giron-Arango et al. using a low frequency curvilinear probe. A 22G 80 mm needle (Stimuplex Ultra 360, B.Braun) will be used.

Wound Infiltration

Intervention Type PROCEDURE

At the end of operation, the surgeon will perform wound infiltration with 20 mL of 0.5 % Ropivacaine.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PENG Block

At the end of surgery, in Post Anesthesia Recovery Room (PACU), PENG block with 20 mL of 0.5 % Ropivacaine will be executed as described by Giron-Arango et al. using a low frequency curvilinear probe. A 22G 80 mm needle (Stimuplex Ultra 360, B.Braun) will be used.

Intervention Type PROCEDURE

Lateral Femoral Cutaneous Nerve Block

At the end of surgery, in Post Anesthesia Recovery Room (PACU), ultrasound guided Lateral Femoral Cutaneous Nerve Block will be performed with 10 mL of 0.5 % Ropivacaine using a high frequency linear probe. A 22G 50 mm needle (Stimuplex Ultra 360, B.Braun) will be used.

Intervention Type PROCEDURE

Wound Infiltration

At the end of operation, the surgeon will perform wound infiltration with 20 mL of 0.5 % Ropivacaine.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective hip replacement surgery performed with a poster-lateral approach
* ASA physical status score \< 4

Exclusion Criteria

* Contraindications to regional anesthesia
* ASA physical status score ≥ 4
* Patient's refusal or inability to sign the informed consent
* Allergies to any drug provided by the study protocol

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No